Bath & Body Works cuts 2025 outlook after Q3 EPS falls to $0.37 from $0.49
Bath & Body Works reported third-quarter 2025 net sales of $1.6 billion, down 1%, and diluted earnings per share of $0.37, compared with $0.49 a year earlier. The company lowered its fourth-quarter and full-year 2025 guidance, citing current business trends and continued consumer pressures, and announced a Consumer First Formula plan with $250 million in cost savings over two years.
Key points
- Third-quarter net sales were $1,594 million, down from $1,610 million; net income was $77 million, compared with $106 million a year earlier.
- Fourth-quarter 2025 net sales are expected to decline by high single digits, and diluted EPS is expected to be at least $1.70, compared with $2.09 in the fourth quarter of 2024.
- Full-year 2025 net sales are now expected to decline by low single digits, versus prior guidance of 1.5% to 2.7% growth; diluted EPS is expected to be at least $2.83, compared with $3.61 in fiscal 2024.
- The Consumer First Formula plan targets $250 million in cost savings over two years, with over half identified for 2026.
The filing
Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 20, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.